BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy

Rheumatology (Oxford). 2010 Jun;49(6):1197-9. doi: 10.1093/rheumatology/keq006a. Epub 2010 Mar 22.

Authors

Chris Deighton¹, Kimme Hyrich, Tina Ding, Jo Ledingham, Mark Lunt, Raashid Luqmani, Patrick Kiely, Marwan Bukhari, Rikki Abernethy, Andrew Ostor, Ailsa Bosworth, Kate Gadsby, Frank McKenna, Diana Finney, Josh Dixey; BSR Clinical Affairs Committee & Standards, Audit and Guidelines Working Group and the BHPR

Affiliation

¹ Rheumatology Department, Royal Derby Hospital, Derby DE22 3NE, UK. chris.deighton@derbyhospitals.nhs.uk

PMID: 20308121
DOI: 10.1093/rheumatology/keq006a

No abstract available

MeSH terms

Adult
Antirheumatic Agents / economics
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / drug therapy*
Arthritis, Rheumatoid / economics
Biological Therapy / economics
Biological Therapy / methods
Eligibility Determination / economics*
Government Agencies
Guidelines as Topic
Humans
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Tumor Necrosis Factor-alpha / economics
Tumor Necrosis Factor-alpha / therapeutic use
United Kingdom

Substances

Antirheumatic Agents
Tumor Necrosis Factor-alpha